SCHEMBL458880

SCHEMBL458880

Cc1cc(C(O)C[N+](=O)[O-])c(F)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.39
MAPT P10636 3/20 0.38
KDM4E B2RXH2 2/20 0.38
ADRA2C P18825 4/20 0.35
ADRA2A P08913 3/20 0.35
ADRA2B P18089 3/20 0.35
ADRA1A P35348 3/20 0.35
ADRB2 P07550 2/20 0.35
CYP3A4 P08684 1/20 0.35
HSD17B10 Q99714 1/20 0.35
APEX1 P27695 1/20 0.34
RAD52 P43351 1/20 0.34
RECQL P46063 1/20 0.34
BLM P54132 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ADRB1 P08588 1/20 0.33
ADRB3 P13945 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6118147 0.86 ALDH1A1 (0.43) ALDH1A1MAPTKDM4EADRA2CADRA2A
SCHEMBL459198 0.83 AKR1B1 (0.43) ALDH1A1MAPTKDM4EADRA2CADRA2A
SCHEMBL17465534 0.79 CES2 (0.45) ALDH1A1MAPTKDM4EADRA2CADRA2A
SCHEMBL826770 0.79 CES2 (0.45) ALDH1A1MAPTKDM4EADRA2CADRA2A
SCHEMBL6128208 0.75 CNR1 (0.47) ALDH1A1CYP3A4CNR1
SCHEMBL458881 0.74 MEN1 (0.30) MAPTMEN1NPC1LMNAHTT
SCHEMBL18590424 0.71 ALDH1A1 (0.42) ALDH1A1RECQLMEN1LMNAKMT2A
SCHEMBL8257851 0.69 PDE2A (0.36) MAPTKDM4EADRA2CADRA2AADRA2B
SCHEMBL27595939 0.69 GRIN2D (0.37) ALDH1A1MAPTKDM4EPDE2ANPC1
SCHEMBL31361810 0.69 ALDH1A1 (0.41) ALDH1A1MAPTADRB2CYP3A4HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed
WO-2013026587-A1 1,4 DISUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2013-02-28 WO disclosed
WO-2012066077-A1 1,4 DI SUBSTITUTED PYRROLIDINE - 3 - YL -AMINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF METABOLIC DISORDERS PROSIDION LIMITED (GB) 2012-05-24 WO disclosed
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed
WO-2011147951-A1 CYCLOAMINO DERIVATIVES AS GPR119 ANTAGONISTS PROSIDION LIMITED (GB) 2011-12-01 WO disclosed